Barely a day after Franklin Templeton doubled down on XRP's "foundational role" in global settlements, the numbers from its freshly launched ETF are telling a story of real Wall Street appetite. The Franklin XRP ETF (XRPZ), trading on NYSE Arca since Monday, clocked 327,286 shares for a cool $7.49 million in volume by late afternoon, neck-and-neck with Bitwise's rival fund at $7.50 million. It wasn't a runaway lead, but for a newcomer in a crowded field, it's a solid flex, especially after a sluggish open that had some traders sweating.
The debut hour set the pace: Bitwise edged ahead with $4.54 million across 195,631 shares, Canary's XRPC nipped at its heels with $4.26 million, and Franklin's XRPZ pulled in $4.00 million from 176,191 shares. Grayscale's GXRP, launching alongside, lagged at just $1.13 million, perhaps a reminder that not all blue-blood names move the needle equally. Combined, the quartet of U.S. spot XRP ETFs hit $13.94 million in that first frantic hour, a volume that analysts like those at JPMorgan say could swell to $8 billion in total inflows over the coming months.
XRP itself rode the wave, climbing 9% to hover around $2.24, bucking a choppy market with a 5% weekly gain. CEO Jenny Johnson didn't hold back in a post-launch note: "This is a significant milestone in institutional adoption," pointing to how XRPZ could funnel retirement funds and legacy portfolios into Ripple's cross-border rails. With fees waived on the first $5 billion through mid-2026, Franklin's clearly playing the long game 0.19% annually after that to lure in the suits who still eye crypto like a volatile ex.
On X, the echo chamber's alive: @Mullen_Army called the $150–250 million day-one projections "turning into reality," while @Steven_Research tallied over $500 million in net inflows across the four funds in their first week, with November 24 alone netting $164 million. Even skeptics are nodding along, as Ripple's post-SEC glow (that $125 million settlement in August) clears the fog for more ETF green lights.
This isn't just another ticker it's proof XRP's graduating from meme status to must-have infrastructure. With Canary and Bitwise already holding over 200 million tokens pre-launch, Franklin's splash feels like the tipping point. If the inflows hold, global payments might never look the same.
The debut hour set the pace: Bitwise edged ahead with $4.54 million across 195,631 shares, Canary's XRPC nipped at its heels with $4.26 million, and Franklin's XRPZ pulled in $4.00 million from 176,191 shares. Grayscale's GXRP, launching alongside, lagged at just $1.13 million, perhaps a reminder that not all blue-blood names move the needle equally. Combined, the quartet of U.S. spot XRP ETFs hit $13.94 million in that first frantic hour, a volume that analysts like those at JPMorgan say could swell to $8 billion in total inflows over the coming months.
XRP itself rode the wave, climbing 9% to hover around $2.24, bucking a choppy market with a 5% weekly gain. CEO Jenny Johnson didn't hold back in a post-launch note: "This is a significant milestone in institutional adoption," pointing to how XRPZ could funnel retirement funds and legacy portfolios into Ripple's cross-border rails. With fees waived on the first $5 billion through mid-2026, Franklin's clearly playing the long game 0.19% annually after that to lure in the suits who still eye crypto like a volatile ex.
On X, the echo chamber's alive: @Mullen_Army called the $150–250 million day-one projections "turning into reality," while @Steven_Research tallied over $500 million in net inflows across the four funds in their first week, with November 24 alone netting $164 million. Even skeptics are nodding along, as Ripple's post-SEC glow (that $125 million settlement in August) clears the fog for more ETF green lights.
This isn't just another ticker it's proof XRP's graduating from meme status to must-have infrastructure. With Canary and Bitwise already holding over 200 million tokens pre-launch, Franklin's splash feels like the tipping point. If the inflows hold, global payments might never look the same.